Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1995 Jun 24;310(6995):1629–1632. doi: 10.1136/bmj.310.6995.1629

Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.

R J Roberts 1, Q D Sandifer 1, M R Evans 1, M Z Nolan-Farrell 1, P M Davis 1
PMCID: PMC2550008  PMID: 7795447

Abstract

OBJECTIVE--To investigate the reasons for poor uptake of immunisation (non-immunisation) and the possible side effects of measles, mumps, and rubella vaccine in a catch up immunisation campaign during a community outbreak of measles. DESIGN--Descriptive study of reasons for non-immunisation and retrospective cohort study of side effects of the vaccine. SETTING--Secondary schools in South Glamorgan. SUBJECTS--Random cluster sample of the parents of 500 children targeted but not immunised and a randomised sample of 2866 of the children targeted. MAIN OUTCOME MEASURES--Reasons for non-immunisation; symptoms among immunised and non-immunised children. RESULTS--Immunisation coverage of the campaign was only 43.4% (7633/17,595). The practical problems experienced included non-return of consent forms (6698/17,595), refusal of immunisation (2061/10,897 forms returned), and absence from school on day of immunisation (1203/8836 children with consent for immunisation). The most common reasons cited for non-immunisation were previous measles infection (145/232), previous immunisation against measles (78/232), and concern about side effects (55/232). Symptoms were equally common among immunised and non-immunised subjects. However, significantly more immunised boys than non-immunised boys reported fever (relative risk 2.31 (95% confidence interval 1.36 to 3.93)), rash (2.00 (1.10 to 3.64), joint symptoms (1.58; 1.05 to 2.38), and headache (1.31 (1.04 to 1.65)). CONCLUSIONS--Many of the objections raised by parents could be overcome by emphasising that primary immunisation does not necessarily confer immunity and that diagnosis of measles is unreliable. Measles, mumps, and rubella vaccine is safe in children aged 11-15.

Full text

PDF
1629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett G., Ramsay M. Improving uptake of immunisation. Mobile children miss out. BMJ. 1993 Sep 11;307(6905):681–682. doi: 10.1136/bmj.307.6905.681-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baxter D. N. Improving immunisation uptake in the United Kingdom. Public Health. 1990 Jul;104(4):267–274. doi: 10.1016/s0033-3506(05)80476-7. [DOI] [PubMed] [Google Scholar]
  3. Benjamin C. M., Chew G. C., Silman A. J. Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine. BMJ. 1992 Apr 25;304(6834):1075–1078. doi: 10.1136/bmj.304.6834.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown D. W., Ramsay M. E., Richards A. F., Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ. 1994 Apr 16;308(6935):1015–1017. doi: 10.1136/bmj.308.6935.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown D. W., Ramsay M. E., Richards A. F., Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ. 1994 Apr 16;308(6935):1015–1017. doi: 10.1136/bmj.308.6935.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen R. T., Goldbaum G. M., Wassilak S. G., Markowitz L. E., Orenstein W. A. An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol. 1989 Jan;129(1):173–182. doi: 10.1093/oxfordjournals.aje.a115106. [DOI] [PubMed] [Google Scholar]
  7. Chen R. T., Moses J. M., Markowitz L. E., Orenstein W. A. Adverse events following measles-mumps-rubella and measles vaccinations in college students. Vaccine. 1991 May;9(5):297–299. doi: 10.1016/0264-410x(91)90053-9. [DOI] [PubMed] [Google Scholar]
  8. Gustafson T. L., Lievens A. W., Brunell P. A., Moellenberg R. G., Buttery C. M., Sehulster L. M. Measles outbreak in a fully immunized secondary-school population. N Engl J Med. 1987 Mar 26;316(13):771–774. doi: 10.1056/NEJM198703263161303. [DOI] [PubMed] [Google Scholar]
  9. Hersh B. S., Markowitz L. E., Hoffman R. E., Hoff D. R., Doran M. J., Fleishman J. C., Preblud S. R., Orenstein W. A. A measles outbreak at a college with a prematriculation immunization requirement. Am J Public Health. 1991 Mar;81(3):360–364. doi: 10.2105/ajph.81.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hull D. Why children are not immunised. J R Coll Physicians Lond. 1987 Jan;21(1):28–31. [PMC free article] [PubMed] [Google Scholar]
  11. Klein N., Morgan K., Wansbrough-Jones M. H. Parents' beliefs about vaccination: the continuing propagation of false contraindications. BMJ. 1989 Jun 24;298(6689):1687–1687. doi: 10.1136/bmj.298.6689.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Li J., Taylor B. Factors affecting uptake of measles, mumps, and rubella immunisation. BMJ. 1993 Jul 17;307(6897):168–171. doi: 10.1136/bmj.307.6897.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lochhead Y. J. Failure to immunize children under 5 years: a literature review. J Adv Nurs. 1991 Feb;16(2):130–137. doi: 10.1111/j.1365-2648.1991.tb01616.x. [DOI] [PubMed] [Google Scholar]
  14. Markowitz L. E., Preblud S. R., Orenstein W. A., Rovira E. Z., Adams N. C., Hawkins C. E., Hinman A. R. Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med. 1989 Jan 12;320(2):75–81. doi: 10.1056/NEJM198901123200202. [DOI] [PubMed] [Google Scholar]
  15. Miller C., Miller E., Rowe K., Bowie C., Judd M., Walker D. Surveillance of symptoms following MMR vaccine in children. Practitioner. 1989 Jan;233(1461):69–73. [PubMed] [Google Scholar]
  16. Morgan-Capner P., Wright J., Miller C. L., Miller E. Surveillance of antibody to measles, mumps, and rubella by age. BMJ. 1988 Sep 24;297(6651):770–772. doi: 10.1136/bmj.297.6651.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Peltola H., Heinonen O. P. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet. 1986 Apr 26;1(8487):939–942. doi: 10.1016/s0140-6736(86)91044-5. [DOI] [PubMed] [Google Scholar]
  18. Seager C., Moriarity J., Ngai A., Staehle B. O., Nalin D. R. Low incidence of adverse experiences after measles or measles-rubella mass revaccination at a college campus. Vaccine. 1994 Aug;12(11):1018–1020. doi: 10.1016/0264-410x(94)90338-7. [DOI] [PubMed] [Google Scholar]
  19. Spruance S. L., Metcalf R., Smith C. B., Griffiths M. M., Ward J. R. Chronic arthropathy associated with rubella vaccination. Arthritis Rheum. 1977 Mar;20(2):741–747. doi: 10.1002/art.1780200216. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES